Louis Ferrari

2012

In 2012, Louis Ferrari earned a total compensation of $2M as President and Chief Executive Officer at SAVIENT PHARMACEUTICALS, a 48% increase compared to previous year.

Compensation breakdown

Bonus$378,125
Non-Equity Incentive Plan$223,125
Option Awards$261,366
Salary$471,955
Stock Awards$700,600
Other$11,250
Total$2,046,421

Ferrari received $700.6K in stock awards, accounting for 34% of the total pay in 2012.

Ferrari also received $378.1K in bonus, $223.1K in non-equity incentive plan, $261.4K in option awards, $472K in salary and $11.3K in other compensation.

Rankings

In 2012, Louis Ferrari's compensation ranked 3,488th out of 11,487 executives tracked by ExecPay. In other words, Ferrari earned more than 69.6% of executives.

ClassificationRankingPercentile
All
3,488
out of 11,487
70th
Division
Manufacturing
1,199
out of 4,253
72nd
Major group
Chemicals And Allied Products
268
out of 1,198
78th
Industry group
Drugs
158
out of 920
83rd
Industry
Medicinal Chemicals and Botanical Products
1
out of 13
92nd
Source: SEC filing on April 29, 2013.

Ferrari's colleagues

We found four more compensation records of executives who worked with Louis Ferrari at SAVIENT PHARMACEUTICALS in 2012.

2012

Richard Crowley

SAVIENT PHARMACEUTICALS

Chief Operating Officer

2012

Kenneth Bahrt

SAVIENT PHARMACEUTICALS

Chief Medical Officer

2012

David Norton

SAVIENT PHARMACEUTICALS

Chief Executive Officer

2012

John Johnson

SAVIENT PHARMACEUTICALS

Chief Executive Officer

You may also like